<?xml version="1.0" encoding="UTF-8"?>
<?xml-stylesheet type="text/xsl" href="/oai-pmh.xsl"?>
<OAI-PMH xmlns="http://www.openarchives.org/OAI/2.0/" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.openarchives.org/OAI/2.0/ http://www.openarchives.org/OAI/2.0/OAI-PMH.xsd">
  <responseDate>2026-09-21T11:11:59Z</responseDate>
  <request identifier="oai:www.ideals.illinois.edu:2142/20296" metadataPrefix="etdms" verb="GetRecord">https://www.ideals.illinois.edu/oai-pmh</request>
  <GetRecord>
    <record>
      <header>
        <identifier>oai:www.ideals.illinois.edu:2142/20296</identifier>
        <datestamp>2023-07-10</datestamp>
        <setSpec>col_2142_5131</setSpec>
        <setSpec>col_2142_25441</setSpec>
        <setSpec>com_2142_5130</setSpec>
        <setSpec>com_2142_25440</setSpec>
        <setSpec>com_2142_14833</setSpec>
      </header>
      <metadata>
        <thesis xmlns="http://www.ndltd.org/standards/metadata/etdms/1.1/" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:dc="http://purl.org/dc/elements/1.1/" xsi:schemaLocation="http://www.ndltd.org/standards/metadata/etdms/1.1/ http://www.ndltd.org/standards/metadata/etdms/1.1/etdms11.xsd http://purl.org/dc/elements/1.1/ http://www.ndltd.org/standards/metadata/etdms/1.1/etdmsdc.xsd">
          <dc:contributor>Shapiro, Stuart Z.</dc:contributor>
          <dc:creator>Rutherford, Mark Stephen</dc:creator>
          <dc:date>2011-05-07T12:35:11Z</dc:date>
          <dc:date>2011-05-07T12:35:11Z</dc:date>
          <dc:date>10000-01-01</dc:date>
          <dc:date>1991</dc:date>
          <dc:description>Macrophages derived in vitro from bone marrow progenitor cells (BMDM) under the influence of CSF-1 or GM-CSF were compared for immune function. CSF-1- and GM-CSF-derived BMDM did not differ in their ability to kill L929 tumor targets or produce IL-6 and LTC$\sb4$ in response to IFN-$\gamma$ and LPS. CSF-1-derived BMDM secreted more TNF-$\alpha$ and PGE$\sb2$ at early stages of culture than did GM-CSF-derived BMDM and required only LPS stimulation to produce NO$\sb2\sp-$. In contrast, GM-CSF-derived BMDM secreted NO$\sb2\sp-$ only following treatment with IFN-$\gamma$ plus LPS. When P815 tumor targets were used, GM-CSF-derived BMDM displayed higher basal and inducible levels of killing than CSF-1-derived BMDM and required only LPS treatment to reach full cytolytic capacity. Additionally, GM-CSF-derived BMDM showed greater listeriacidal capacity than did CSF-1-derived BMDM, particularly following IFN-$\gamma$ plus LPS treatment. To assess immunocompetence under conditions resembling those of inflammatory sites, BMDM function was examined following treatment with PGE$\sb2$ or in conditions of reduced L-arginine concentration. PGE$\sb2$ (10$\sp{-6}$-10$\sp{-8}$ M) had no effect on BMDM ability to cytolyze L929 cells, kill intracellular Listeria, or produce NO$\sb2\sp-$, but GM-CSF-derived BMDM were inhibited 33% for cytolysis of K562 tumor cells. Interestingly, GM-CSF-derived BMDM were much less sensitive than CSF-1-derived BMDM for PGE$\sb2$, but not cAMP-mediated inhibition of TNF-$\alpha$. Arginine depletion blocked NO$\sb2\sp-$ production by both BMDM populations and the listeriacidal activity induced by IFN-$\gamma$ plus LPS was abolished.</dc:description>
          <dc:description>Macrophages were elicited in CB-17 and scid mice by repeated injection of GM-CSF. Following challenge with Listeria, scid mice which had been pretreated with GM-CSF showed reduced numbers of bacteria in the liver and spleens. CB-17 mice were unaffected by GM-CSF administration.</dc:description>
          <dc:description>When used alone, neither CSF-1 nor GM-CSF elicited TNF-$\alpha$, NO$\sb2\sp-$, or PGE$\sb2$ secretion. GM-CSF primed CSF-1-derived BMDM for enhanced LPS-induced TNF-$\alpha$, NO$\sb2\sp-$, and PGE$\sb2$ secretion, and for augmented cytolysis of P815, but not K562 tumor cells. Thus, GM-CSF elicits a macrophage population with functional signal requirements distinct from those of CSF-1-derived BMDM and is a more effective biological response modifier for macrophage function than is CSF-1.</dc:description>
          <dc:description>Made available in DSpace on 2011-05-07T12:35:11Z (GMT). No. of bitstreams: 2
license.txt: 4922 bytes, checksum: 910b249b4beec47e7ab768910c8f966f (MD5)
9124479.pdf: 5604868 bytes, checksum: f344b15fc1e4283f91fcce7c0589c192 (MD5)
  Previous issue date: 1991</dc:description>
          <dc:description>Item marked as restricted to the 'UIUC Users [automated]' Group (id=2) by Howard Ding (hding2@illinois.edu) on 2011-05-07T14:42:56Z
Item is restricted indefinitely.</dc:description>
          <dc:description>Restriction data tranferred 2014-07-01T11:18:44-05:00
Original Data
Group with Access UIUC Users [automated]
Release Date: none
Reason: ETDs are only available to UIUC Users without author permission</dc:description>
          <dc:description>ETDs are only available to UIUC Users without author permission</dc:description>
          <dc:description>U of I Only</dc:description>
          <dc:identifier>AAI9124479</dc:identifier>
          <dc:identifier>(UMI)AAI9124479</dc:identifier>
          <dc:identifier>http://hdl.handle.net/2142/20296</dc:identifier>
          <dc:language>eng</dc:language>
          <dc:rights>Copyright 1991 Rutherford, Mark Stephen</dc:rights>
          <dc:subject>Biology, Cell</dc:subject>
          <dc:subject>Health Sciences, Immunology</dc:subject>
          <dc:title>Differentiation and activation of functionally distinct macrophage populations by CSF-1 and GM-CSF</dc:title>
          <dc:type>text</dc:type>
          <degree>
            <department>Pathobiology</department>
            <discipline>Pathobiology</discipline>
            <grantor>University of Illinois at Urbana-Champaign</grantor>
            <level>Dissertation</level>
            <name>Ph.D.</name>
          </degree>
        </thesis>
      </metadata>
    </record>
  </GetRecord>
</OAI-PMH>
